(Q48575097)

English

Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-κB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral Ischemia

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-κB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral Ischemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

0 references

cerebral infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Jin-Tai Yu

9

0 references

8

object named as

Lan Tan

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

2

object named as

Teng Jiang

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

Qiao-Quan Zhang

3

object named as

Qiao-Quan Zhang

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

author name string

Xi-Chen Zhu

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

Lei Cao

4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

Meng-Shan Tan

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

Hui-Fu Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

Zheng-Zheng Ding

7

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

publication date

30 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

Molecular Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

52

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

375-385

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Effects of Metformin in Experimental Stroke

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: interference of AMPK/PGC-1α pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Acute anti-inflammatory approaches to ischemic stroke

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Inflammatory mechanisms after ischemia and stroke

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

NF-kappaB signaling in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Nuclear factor-kappaB contributes to infarction after permanent focal ischemia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Potential contribution of NF-kappaB in neuronal cell death in the glutathione peroxidase-1 knockout mouse in response to ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

NF-κB and innate immunity in ischemic stroke

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Suppressing inflammation by inhibiting the NF-κB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Neuroprotective potential of the NF-κB inhibitor peptide IKK-NBD in cerebral ischemia-reperfusion injury.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Metformin improves healthspan and lifespan in mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Metformin therapy in a transgenic mouse model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Ischemic preconditioning provides neuroprotection by induction of AMP-activated protein kinase-dependent autophagy in a rat model of ischemic stroke

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

A semiautomated method for measuring brain infarct volume.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

IL12/23 p40 inhibition ameliorates Alzheimer's disease-associated neuropathology and spatial memory in SAMP8 mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

NF-kappaB: a multifaceted transcription factor regulated at several levels

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

NF-kappaB is activated and promotes cell death in focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Recombinant adenoviral expression of dominant negative IkappaBalpha protects brain from cerebral ischemic injury

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

The inflammatory response in stroke

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Astrocytes: biology and pathology

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Immune function of astrocytes

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8866-7

21 January 2018

Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25172433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25172433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25172433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12035-014-8866-7

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25172433

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48575097&oldid=2209604735"